Symbols / WOK
WOK Chart
About
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 1.74M |
| Enterprise Value | 6.79M | Income | -1.07M | Sales | 9.85M |
| Book/sh | 17.70 | Cash/sh | 3.35 | Dividend Yield | — |
| Payout | 0.00% | Employees | 238 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.18 | P/B | 0.08 | P/C | — |
| EV/EBITDA | -4.32 | EV/Sales | 0.69 | Quick Ratio | 0.39 |
| Current Ratio | 1.71 | Debt/Eq | 30.32 | LT Debt/Eq | — |
| EPS (ttm) | -374.29 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -14.40% | Earnings | — | ROA | -4.49% |
| ROE | -6.45% | ROIC | — | Gross Margin | 23.81% |
| Oper. Margin | -17.52% | Profit Margin | -10.89% | Shs Outstand | 1.22M |
| Shs Float | 1.22M | Short Float | 7.29% | Short Ratio | 0.17 |
| Short Interest | — | 52W High | 10800.00 | 52W Low | 1.23 |
| Beta | — | Avg Volume | 788.10K | Volume | 28.71K |
| Target Price | — | Recom | None | Prev Close | $1.43 |
| Price | $1.34 | Change | -6.29% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.34
Latest analyst target
3. DCF / Fair value
$-81.52
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.34
Low
—
High
—
Mean
—
News
RSS: Latest WOK news- AI-powered blood test machine designed to support earlier disorder screening - Stock Titan Mon, 29 Dec 2025 08
- Revenues Working Against WORK Medical Technology Group LTD's (NASDAQ:WOK) Share Price Following 100% Dive - simplywall.st Fri, 09 Jan 2026 08
- WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 - Quiver Quantitative Wed, 24 Dec 2025 08
- Why Did WOK Stock Surge Over 50% Today? - Stocktwits Mon, 29 Dec 2025 15
- Why Work Medical (WOK) Stock Jumped 50% After Hours? - WORK Medical Tech Gr (NASDAQ:WOK) - Benzinga Wed, 22 Oct 2025 07
- WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025) - TechStock² Mon, 15 Dec 2025 08
- Why Investors Shouldn't Be Surprised By WORK Medical Technology Group LTD's (NASDAQ:WOK) 26% Share Price Plunge - Sahm Sat, 15 Nov 2025 08
- Nasdaq to delist WORK Medical due to low share price - Investing.com ue, 14 Oct 2025 07
- WORK Medical Technology Group Enters Sales Agreement to Raise $200 Million - TipRanks Mon, 24 Nov 2025 08
- WOK Stock Reaches Tumbling Heights: Quick Overview - StocksToTrade Mon, 29 Dec 2025 08
- WOK Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 05
- WORK Medical Technology Group LTD Implements Share Consolidation to Meet Nasdaq Requirements - TipRanks ue, 21 Oct 2025 07
- WORK Medical to implement 1-for-100 reverse stock split - Investing.com hu, 16 Oct 2025 07
- WORK Medical Technology Group Receives Nasdaq Compliance Extension to Regain Minimum Bid Price Requirement - Quiver Quantitative Fri, 10 Oct 2025 07
- WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience - GlobeNewswire ue, 21 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.25 | 0.03 | 0.25 | 0.15 |
| NormalizedEBITDA | 344.66K | -1.70M | 2.11M | 4.72M |
| TotalUnusualItems | 0.00 | |||
| TotalUnusualItemsExcludingGoodwill | 0.00 | |||
| NetIncomeFromContinuingOperationNetMinorityInterest | -1.07M | -3.49M | 112.03K | 865.21K |
| ReconciledDepreciation | 923.11K | 1.41M | 1.60M | 3.26M |
| ReconciledCostOfRevenue | 7.50M | 8.64M | 9.42M | 15.29M |
| EBITDA | 344.66K | -1.70M | 2.11M | 4.72M |
| EBIT | -578.45K | -3.11M | 503.13K | 1.47M |
| NetInterestIncome | -321.84K | -545.84K | -367.32K | -351.00K |
| InterestExpense | 503.52K | 557.57K | 392.74K | 352.97K |
| InterestIncome | 181.68K | 11.73K | 25.42K | 1.97K |
| NormalizedIncome | -1.07M | -3.49M | 112.03K | 865.21K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -1.07M | -3.49M | 112.03K | 865.21K |
| TotalExpenses | 10.74M | 15.21M | 13.08M | 17.89M |
| DilutedAverageShares | 1.29K | 1.45K | 1.55K | 1.45K |
| BasicAverageShares | 1.29K | 1.45K | 1.45K | 1.45K |
| DilutedEPS | -2.70K | 77.26 | 558.20 | 4.11K |
| BasicEPS | -2.70K | 77.26 | 596.70 | 4.11K |
| DilutedNIAvailtoComStockholders | -1.07M | -3.49M | 112.03K | 865.21K |
| NetIncomeCommonStockholders | -1.07M | -3.49M | 112.03K | 865.21K |
| NetIncome | -1.07M | -3.49M | 112.03K | 865.21K |
| MinorityInterests | 128.36K | 48.09K | 48.65K | -78.92K |
| NetIncomeIncludingNoncontrollingInterests | -1.20M | -3.54M | 63.38K | 944.13K |
| NetIncomeContinuousOperations | -1.20M | -3.54M | 63.38K | 944.13K |
| TaxProvision | 119.05K | -125.29K | 47.01K | 169.44K |
| PretaxIncome | -1.08M | -3.67M | 110.39K | 1.11M |
| OtherIncomeExpense | 135.40K | 578.76K | -8.75K | -360.41K |
| OtherNonOperatingIncomeExpenses | 135.40K | 578.76K | -8.75K | -360.41K |
| SpecialIncomeCharges | 0.00 | |||
| ImpairmentOfCapitalAssets | 0.00 | |||
| NetNonOperatingInterestIncomeExpense | -321.84K | -545.84K | -367.32K | -351.00K |
| InterestExpenseNonOperating | 503.52K | 557.57K | 392.74K | 352.97K |
| InterestIncomeNonOperating | 181.68K | 11.73K | 25.42K | 1.97K |
| OperatingIncome | -895.53K | -3.70M | 486.46K | 1.82M |
| OperatingExpense | 3.24M | 6.57M | 3.66M | 2.59M |
| OtherOperatingExpenses | -1.60M | -346.57K | -74.23K | -1.19M |
| ResearchAndDevelopment | 435.31K | 302.51K | 301.64K | 183.90K |
| SellingGeneralAndAdministration | 4.41M | 6.61M | 3.43M | 3.60M |
| SellingAndMarketingExpense | 2.08M | 2.05M | 1.57M | 1.03M |
| GeneralAndAdministrativeExpense | 2.33M | 4.56M | 1.86M | 2.56M |
| OtherGandA | 2.33M | 4.56M | 1.86M | 2.56M |
| GrossProfit | 2.34M | 2.87M | 4.14M | 4.42M |
| CostOfRevenue | 7.50M | 8.64M | 9.42M | 15.29M |
| TotalRevenue | 9.85M | 11.51M | 13.57M | 19.71M |
| ExciseTaxes | 184.80K | |||
| OperatingRevenue | 9.83M | 11.41M | 13.41M | 19.47M |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 10.36K | 1.46K | 1.45K | 1.45K |
| ShareIssued | 10.36K | 1.46K | 1.45K | 1.45K |
| NetDebt | 2.30M | 6.91M | 7.40M | 5.48M |
| TotalDebt | 6.42M | 13.47M | 9.10M | 6.30M |
| TangibleBookValue | 17.38M | 12.14M | 8.88M | 9.05M |
| InvestedCapital | 24.73M | 26.65M | 18.87M | 16.21M |
| WorkingCapital | 8.48M | 647.03K | 3.23M | 2.35M |
| NetTangibleAssets | 17.38M | 12.14M | 8.88M | 9.05M |
| CapitalLeaseObligations | 25.50K | 0.00 | 99.69K | 87.09K |
| CommonStockEquity | 18.34M | 13.19M | 9.88M | 10.00M |
| TotalCapitalization | 18.34M | 13.19M | 9.88M | 10.00M |
| TotalEquityGrossMinorityInterest | 21.16M | 16.07M | 10.99M | 11.19M |
| MinorityInterest | 2.83M | 2.88M | 1.11M | 1.19M |
| StockholdersEquity | 18.34M | 13.19M | 9.88M | 10.00M |
| OtherEquityInterest | -6.25K | -6.25K | -6.25K | -6.25K |
| GainsLossesNotAffectingRetainedEarnings | 291.00K | 491.27K | 210.65K | 410.41K |
| OtherEquityAdjustments | 291.00K | 491.27K | 210.65K | 410.41K |
| RetainedEarnings | 4.96M | 6.08M | 9.58M | 9.51M |
| AdditionalPaidInCapital | 13.04M | 6.62M | 85.01K | 85.01K |
| CapitalStock | 51.80K | 7.30K | 6.25K | 6.25K |
| CommonStock | 51.80K | 7.30K | 6.25K | 6.25K |
| TotalLiabilitiesNetMinorityInterest | 11.99M | 20.18M | 18.97M | 14.35M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 20.06K | 0.00 | 50.13K | 94.04K |
| NonCurrentDeferredLiabilities | 1.30K | 0.00 | 25.53K | 347.55K |
| NonCurrentDeferredTaxesLiabilities | 1.30K | 0.00 | 25.53K | 347.55K |
| LongTermDebtAndCapitalLeaseObligation | 18.76K | 0.00 | 50.13K | 68.50K |
| LongTermCapitalLeaseObligation | 18.76K | 0.00 | 50.13K | 68.50K |
| CurrentLiabilities | 11.97M | 20.18M | 18.92M | 14.26M |
| CurrentDeferredLiabilities | 402.41K | 625.33K | 776.21K | 744.11K |
| CurrentDeferredRevenue | 402.41K | 625.33K | 776.21K | 744.11K |
| CurrentDebtAndCapitalLeaseObligation | 6.40M | 13.47M | 9.05M | 6.23M |
| CurrentCapitalLeaseObligation | 6.74K | 0.00 | 49.56K | 18.59K |
| CurrentDebt | 6.39M | 13.47M | 9.00M | 6.21M |
| OtherCurrentBorrowings | 142.50K | 155.56K | 239.66K | 6.60M |
| LineOfCredit | 6.39M | 13.32M | 8.84M | 5.97M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 508.57K | 412.07K | ||
| PayablesAndAccruedExpenses | 5.17M | 6.09M | 9.10M | 7.28M |
| Payables | 5.17M | 6.09M | 9.10M | 7.28M |
| OtherPayable | 957.10K | 1.15M | 3.01M | 1.73M |
| DuetoRelatedPartiesCurrent | 12.77K | 1.07M | 4.05K | 627.22K |
| TotalTaxPayable | 2.48M | 2.37M | 2.13M | 1.72M |
| IncomeTaxPayable | 501.48K | 508.73K | 736.59K | 619.58K |
| AccountsPayable | 1.72M | 1.50M | 3.96M | 3.20M |
| TotalAssets | 33.16M | 36.25M | 29.96M | 25.54M |
| TotalNonCurrentAssets | 12.70M | 15.42M | 7.81M | 8.93M |
| NonCurrentDeferredAssets | 0.00 | 112.92K | 66.87K | 0.00 |
| NonCurrentDeferredTaxesAssets | 0.00 | 112.92K | 66.87K | 0.00 |
| GoodwillAndOtherIntangibleAssets | 959.12K | 1.04M | 998.45K | 949.96K |
| OtherIntangibleAssets | 959.12K | 1.04M | 998.45K | 949.96K |
| NetPPE | 11.74M | 14.27M | 6.74M | 7.98M |
| AccumulatedDepreciation | -6.84M | -6.27M | -11.15M | -10.73M |
| GrossPPE | 18.58M | 20.54M | 17.89M | 18.71M |
| ConstructionInProgress | 1.13M | 2.89M | 0.00 | 0.00 |
| OtherProperties | 26.06K | 114.13K | 92.31K | |
| MachineryFurnitureEquipment | 5.64M | 5.73M | 12.38M | 13.09M |
| BuildingsAndImprovements | 11.78M | 11.92M | 5.40M | 5.53M |
| Properties | 0.00 | 0.00 | 0.00 | 5.53M |
| CurrentAssets | 20.46M | 20.83M | 22.15M | 16.61M |
| OtherCurrentAssets | 41.93K | 90.85K | 59.53K | 8.90K |
| CurrentDeferredAssets | 0.00 | 1.36M | 619.84K | 0.00 |
| RestrictedCash | 0.00 | 400.00K | 41.19K | 42.24K |
| PrepaidAssets | 1.42M | 4.84M | 3.49M | 4.70M |
| Inventory | 2.46M | 3.18M | 4.62M | 4.36M |
| InventoriesAdjustmentsAllowances | -355.04K | -251.64K | -241.29K | -229.24K |
| FinishedGoods | 1.40M | 1.37M | 2.09M | 2.21M |
| WorkInProcess | 878.32K | 1.46M | 2.03M | 1.75M |
| RawMaterials | 527.25K | 605.15K | 741.99K | 629.67K |
| Receivables | 12.45M | 5.75M | 10.99M | 6.15M |
| ReceivablesAdjustmentsAllowances | 0.00 | -427.35K | -352.94K | -370.75K |
| OtherReceivables | 593.33K | 613.58K | 492.89K | 130.73K |
| DuefromRelatedPartiesCurrent | 10.79M | 1.43M | 2.93M | 160.41K |
| LoansReceivable | 1.05M | 2.51M | 4.46M | 2.58M |
| AccountsReceivable | 615.84K | 1.65M | 3.33M | 3.29M |
| AllowanceForDoubtfulAccountsReceivable | -71.53K | -1.00M | -1.01M | -1.34M |
| GrossAccountsReceivable | 687.37K | 2.65M | 4.34M | 4.63M |
| CashCashEquivalentsAndShortTermInvestments | 4.09M | 6.56M | 1.60M | 731.18K |
| CashAndCashEquivalents | 4.09M | 6.56M | 1.60M | 731.18K |
| Line Item | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| FreeCashFlow | 4.91M | -11.49M | 1.63M | -4.27M |
| RepaymentOfDebt | -24.61M | -15.08M | -14.39M | -17.77M |
| IssuanceOfDebt | 18.82M | 16.13M | 9.13M | 8.08M |
| IssuanceOfCapitalStock | 6.90M | 7.37M | 0.00 | 0.00 |
| CapitalExpenditure | -1.33M | -9.26M | -583.30K | -2.01M |
| InterestPaidSupplementalData | 508.52K | 543.75K | 312.04K | 312.28K |
| IncomeTaxPaidSupplementalData | 8.10K | 9.97K | 160.16K | 340.02K |
| EndCashPosition | 4.09M | 6.56M | 1.64M | 773.42K |
| BeginningCashPosition | 6.56M | 1.64M | 773.42K | 873.13K |
| EffectOfExchangeRateChanges | -207.36K | 555.46K | -33.85K | -59.82K |
| ChangesInCash | -2.26M | 4.36M | 897.71K | -39.89K |
| FinancingCashFlow | -898.21K | 15.66M | -728.72K | 3.57M |
| CashFlowFromContinuingFinancingActivities | -898.21K | 15.66M | -728.72K | 3.57M |
| NetOtherFinancingCharges | -2.00M | 7.23M | 4.54M | 13.26M |
| NetCommonStockIssuance | 6.90M | 7.37M | 0.00 | 0.00 |
| CommonStockIssuance | 6.90M | 7.37M | 0.00 | 0.00 |
| NetIssuancePaymentsOfDebt | -5.79M | 1.05M | -5.26M | -9.69M |
| NetShortTermDebtIssuance | -6.66M | -548.71K | -2.56M | -9.49M |
| ShortTermDebtPayments | -24.61M | -13.94M | -11.67M | -16.74M |
| ShortTermDebtIssuance | 17.95M | 13.39M | 9.11M | 7.25M |
| NetLongTermDebtIssuance | 860.78K | 1.60M | -2.70M | -201.59K |
| LongTermDebtPayments | 0.00 | -1.13M | -2.72M | -1.03M |
| LongTermDebtIssuance | 860.78K | 2.73M | 23.56K | 829.04K |
| InvestingCashFlow | -7.61M | -9.06M | -583.30K | -1.35M |
| CashFlowFromContinuingInvestingActivities | -7.61M | -9.06M | -583.30K | -1.35M |
| NetOtherInvestingChanges | -6.66M | |||
| NetInvestmentPurchaseAndSale | -157.00K | |||
| PurchaseOfInvestment | -157.00K | |||
| NetBusinessPurchaseAndSale | -85.11K | 0.00 | 0.00 | 63.62K |
| SaleOfBusiness | 0.00 | 0.00 | 63.62K | 0.00 |
| PurchaseOfBusiness | -85.11K | 0.00 | 0.00 | |
| NetIntangiblesPurchaseAndSale | 0.00 | -33.31K | -127.91K | 0.00 |
| PurchaseOfIntangibles | 0.00 | -33.31K | -127.91K | 0.00 |
| NetPPEPurchaseAndSale | -859.58K | -9.03M | -455.39K | -1.41M |
| SaleOfPPE | 472.93K | 194.33K | 0.00 | 601.76K |
| PurchaseOfPPE | -1.33M | -9.23M | -455.39K | -2.01M |
| OperatingCashFlow | 6.24M | -2.23M | 2.21M | -2.26M |
| CashFlowFromContinuingOperatingActivities | 6.24M | -2.23M | 2.21M | -2.26M |
| ChangeInWorkingCapital | 6.44M | -107.51K | 461.85K | -7.13M |
| ChangeInOtherWorkingCapital | -1.59M | 1.60M | -3.91M | -7.88K |
| ChangeInOtherCurrentLiabilities | -5.84K | -2.03K | -51.76K | -5.21K |
| ChangeInPayablesAndAccruedExpense | 213.03K | -4.33M | 2.69M | -4.82M |
| ChangeInAccruedExpense | -32.47K | -1.52M | 1.69M | 917.30K |
| ChangeInPayable | 245.50K | -2.80M | 1.00M | -5.74M |
| ChangeInAccountPayable | 245.50K | -2.55M | 864.59K | -5.82M |
| ChangeInTaxPayable | 0.00 | -250.42K | 136.51K | 81.43K |
| ChangeInIncomeTaxPayable | 0.00 | -250.42K | 136.51K | 81.43K |
| ChangeInPrepaidAssets | 6.23M | -767.64K | 2.27M | -385.89K |
| ChangeInInventory | 568.67K | 1.58M | -400.54K | 2.05M |
| ChangeInReceivables | 1.02M | 1.82M | -131.95K | -3.96M |
| ChangesInAccountReceivables | 1.02M | 1.82M | -131.95K | -3.96M |
| OtherNonCashItems | -158.43K | |||
| ProvisionandWriteOffofAssets | -155.64K | 12.16K | 149.50K | 1.11M |
| AssetImpairmentCharge | 105.60K | 762.00 | 18.32K | -117.33K |
| DeferredTax | 111.15K | -46.04K | -94.53K | -314.01K |
| DeferredIncomeTax | 111.15K | -46.04K | -94.53K | -314.01K |
| DepreciationAmortizationDepletion | 923.11K | 1.41M | 1.60M | 3.26M |
| DepreciationAndAmortization | 923.11K | 1.41M | 1.60M | 3.26M |
| OperatingGainsLosses | 178.51K | 42.50K | 8.09K | -10.87K |
| GainLossOnSaleOfPPE | 178.38K | 42.50K | 8.09K | -10.87K |
| GainLossOnSaleOfBusiness | 126.00 | 0.00 | 0.00 | |
| NetIncomeFromContinuingOperations | -1.20M | -3.54M | 63.38K | 944.13K |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for WOK
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|